Global Next Generation Bioprinting Market is projected to record a CAGR of 29.82 % during the forecast period of 2024-2031.
Global Next Generation Bioprinting Market is projected to record a CAGR of 29.82 % during the forecast period of 2024-2031.
Market Analysis:
Next-generation bioprinting encompasses cutting-edge techniques and approaches that enable the accurate placement of biological substances, including cells, biomaterials, and bioactive compounds, in order to fabricate intricate three-dimensional (3D) tissue formations. Bioprinting, in contrast to conventional 3D printing, focuses on replicating the intricate structure and cellular makeup of natural tissues. Its purpose is to advance regenerative medicine, drug discovery, and tissue engineering by utilizing organic materials.
The future of bioprinting shows immense potential in propelling the area of tissue engineering and regenerative medicine forward. It allows for the creation of intricate and fully functional tissues and organs, paving the way for their use in medical treatments. Ongoing research and advancements in bioprinting technology and biomaterials are propelling the progress of increasingly advanced and medically significant tissue structures.
Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1941
Recent Developments:
- In April 2024, Pelobiotech GmbH, a biotechnology business located in Planegg/Martinsried, declared a strategic alliance with HVD Life Science Vertriebs GmbH to distribute Poietis’ cutting-edge Bioprinting platform, NGB-RTM, in Germany. The anticipated strategic alliance aimed to set new benchmarks in the realm of biotechnological research, granting German scientists and researchers the opportunity to utilize cutting-edge bioprinting technology.
- In Jan 2021, 3D Systems made the decision to significantly increase its development endeavours, specifically concentrating on regenerative medicine and bioprinting solutions. The decision was inspired by the substantial advancements made through the partnership with United Therapeutics Corporation and its subsidiary, Lung Biotechnology PBC, in the creation of 3D printing systems for solid-organ scaffolds.
List of Prominent Players in the Next Generation Bioprinting Market:
- DirectSync Surgical
- Poietis
- Regenhu
- 3D Systems, Inc.
- GeSiM
- Stratasys
- ROKIT Healthcare
- Sculpteo
- Smart3D
- VIVAX BIO
- EnvisionTEC
- EOS GmbH Electro Optical System
- Materialise NV
- Dassault Systèmes
- Organovo Holdings, Inc.
- Cellink
- Izumi International, Inc
- Advanced Solutions Life Sciences. LLC.
Next-Generation Bioprinting Market Dynamics:
Market Drivers: Growing Need for Organ Transplants
There is a significant scarcity of organs available for transplantation on a global scale, leading to lengthy waiting lists and elevated patient mortality rates. Next-generation bioprinting has the potential to address this shortfall by allowing the creation of patient-specific organs and tissues, hence lowering reliance on traditional organ donation. This market’s growth is being driven by technological advancements in 3D bioprinting, an ageing population, a growing burden of chronic diseases, and increased R&D investments. Furthermore, rising demand for organ transplants is likely to create considerable market growth possibilities.
Challenges: Complexity of Tissue Engineering
Bioprinting allows us to create functional tissues and organs by duplicating the precise structure and composition of genuine tissues. Achieving the necessary tissue complexity, vascularization, and functionality is still a substantial problem, especially for larger and more complicated organs. The lack of experienced professionals and the high cost of 3D bioprinting limit the market’s growth.
Asia Pacific Is Predicted A Rapid Growth With The Highest CAGR During The Forecast Period.
Asia Pacific’s Next Generation Bioprinting Market is likely to register a significant revenue share and to develop at a rapid CAGR in the near future. This is due to the enormous number of people requesting organ transplants in India, China, Japan, and Southeast Asia. Growing awareness of 3D printing technology, more foreign investment, and favourable government regulations are driving regional industry growth. Moreover, collaboration between academic institutions, research organizations, and industry players is driving innovation and technology transfer in the Asia Pacific bioprinting market.
Segmentation of Next Generation Bioprinting Market-
Next Generation Bioprinting Market By Type-
- Extrusion-based Technology
- Laser-based Technology
- Inkjet-based Technology
- Others
Next Generation Bioprinting Market By Application-
- Biomedical Applications
- Other Applications
Next Generation Bioprinting Market By End-User-
- Pharmaceutical and Biotechnology Companies
- Academic Research and Development
- Other End Users
Next Generation Bioprinting Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Order the 180 Pages Detailed Report https://www.insightaceanalytic.com/buy-report/1941
Call: North America +1 551 226 6109 Email: diana.dsouza@insightaceanalytics.com